Cayman Chemical GenIposIdIc AcId 50mg
An iridoid glycoside with diverse biological activities; inhibits TPA-induced EAr edema in mice by 91.01% when administered topically at 0.1 mg/ear; increases survival rate, attenuates increases in ALT activity and TNF-α levels in serum, as well as hepatic levels of MDA, and prevents decreases in hepatic GSH levels in a mouse model of fulminant hepatic failure induced by D-galactosamine and LPS at 50 mg/kg; decreases systolic blood pressure and heart rate and increases plasma levels of ANP in spontaneously hypertensive rats at 100 mg/kg